drugset / Trial / NCT00226564

Genetic Determinants of Opioids Analgesia

NCT00226564

Completed 100 enrolled Hadassah Medical Organization
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The response to opioids varies greatly among individuals. Some of these variability is accounted for by genetic factors. The present study was designed to evaluate the possibility that genetic polymorphism in the gene encoding for mu opioid receptor may explain variability in the response to alfentanil during lithotripsy.

Timeline

Start
1997-08
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfentanil Other / unclassified

Indications